Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors (Q34402770)

1 August 2017

Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors (English)

1 reference

1 August 2017

0 references

Florence Brellier

1

1 reference

1 August 2017

Enrico Martina

2

1 reference

1 August 2017

Martin Degen

3

1 reference

1 August 2017

Nathalie Heuzé-Vourc'h

4

1 reference

1 August 2017

Agnès Petit

5

1 reference

1 August 2017

Thomas Kryza

6

1 reference

1 August 2017

Yves Courty

7

1 reference

1 August 2017

Luigi Terracciano

8

1 reference

1 August 2017

Christian Ruiz

9

1 reference

1 August 2017

Ruth Chiquet-Ehrismann

10

1 reference

1 August 2017

4 September 2012

1 reference

1 August 2017

BMC Clinical Pathology

1 reference

1 August 2017

12

1 reference

1 August 2017

14

1 reference

describes a project that uses

1 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3444373/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

exact match

https://scigraph.springernature.com/pub.10.1186/1472-6890-12-14

0 references

cites work

The adhesion modulating properties of tenascin-W.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Cancer invasion and the microenvironment: plasticity and reciprocity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Twisted tango: brain tumor neurovascular interactions

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Advances in tenascin-C biology

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

How do tenascins influence the birth and life of a malignant cell?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Tenascins and the importance of adhesion modulation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Hallmarks of Cancer: The Next Generation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

A multimodal nanoparticle-based cancer imaging probe simultaneously targeting nucleolin, integrin αvβ3 and tenascin-C proteins

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Expression of tenascin-C and its isoforms in the breast

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

The perivascular niche microenvironment in brain tumor progression

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Tenascin-W: an extracellular matrix protein associated with osteogenesis and cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Tenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

The role of tenascin-C in tissue injury and tumorigenesis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

A perivascular niche for brain tumor stem cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Tenascin-C induced signaling in cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Tumor targeting by an aptamer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Tissue repair and stem cell renewal in carcinogenesis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Murine tenascin-W: a novel mammalian tenascin expressed in kidney and at sites of bone and smooth muscle development

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Tenascins: regulation and putative functions during pathological stress

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Tenascin isoforms: possible targets for diagnosis and therapy of cancer and mechanisms regulating their expression

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Tenascin is a stromal marker for epithelial malignancy in the mammary gland

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3444373

Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C.

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6890-12-14

The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6890-12-14

Three clinical-stage tumor targeting antibodies reveal differential expression of oncofetal fibronectin and tenascin-C isoforms in human lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6890-12-14

Differential vascular expression and regulation of oncofetal tenascin-C and fibronectin variants in renal cell carcinoma (RCC): implications for an individualized angiogenesis-related targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6890-12-14

A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6890-12-14

A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6890-12-14

Dermo-epidermal separation is associated with induced tenascin expression in human skin

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22947174

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22947174

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1472-6890-12-14

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference